Complex causal association between immunophenotypes and adenomyosis: Univariable, bidirectional, and multivariable Mendelian randomization
article
OA: hybrid
CC0
AI-generated summary
This Mendelian randomization study identified 26 immunophenotypes causally associated with adenomyosis, with 5 identified as risk factors and 8 as protective factors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This study aimed to explore the causal link between immunophenotypes and adenomyosis using Mendelian randomization (MR). We conducted a bidirectional MR analysis on 731 immunophenotypes, employing inverse-variance weighted (IVW) as the primary method, supplemented by MR-Egger, weighted mode, and weighted median analyses. Sensitivity analyses were performed to ensure result robustness. Multivariable MR was also used to control for confounding among immune cells. Results showed that 16 immunophenotypes were positively associated with adenomyosis (p 1), while 10 had a negative correlation (p < 0.05, OR < 1). Reverse MR revealed 16 positive and 4 negative correlations with adenomyosis (P 1 or < 1). Multivariable MR identified 5 risk factors and 8 protective factors for adenomyosis (P 1 or < 1). This study clarifies the significant correlation between immune cells and adenomyosis, offering valuable insights for future clinical research.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (70)
- CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions via openalex
- Characterization of endometriosis-associated immune cell infiltrates (EMaICI) via openalex
- Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis via openalex
- Cytokine Network of Eutopic and Ectopic Endometrium in Women with Adenomyosis via openalex
- Different macrophages equally induce EMT in endometria of adenomyosis and normal via openalex
- Expression of γδT Cells and Adhesion Molecules in Endometriotic Tissue in Patients With Endometriosis and Adenomyosis via openalex
- Fractalkine/<scp>CX</scp>3<scp>CR</scp>1 is involved in the pathogenesis of endometriosis by regulating endometrial stromal cell proliferation and invasion via openalex
- Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis via openalex
- Immunological changes associated with adenomyosis: a systematic review via openalex
- Immunotherapy: A promising novel endometriosis therapy via openalex
- Induction of endometriosis alters the peripheral and endometrial regulatory T cell population in the non-human primate via openalex
- Inflammation in the uterus induces phosphorylated extracellular signal‐regulated kinase and substance P immunoreactivity in dorsal root ganglia neurons innervating both uterus and colon in rats via openalex
- L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner. via openalex
- Macrophage-associated immune checkpoint CD47 blocking ameliorates endometriosis via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Serum Levels of Interleukins in Endometriosis Patients: A Systematic Review and Meta-analysis via openalex
- Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu via openalex
- The Disease Phenotype of Adenomyosis-Affected Women Correlates With Specific Serum Cytokine Profiles via openalex
- The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: adenomyosis and macrophages via openalex
- The Expression of Toll-like receptors in eutopic and ectopic endometrium and its implication in the inflammatory pathogenesis of adenomyosis via openalex
- The Promises of Natural Killer Cell Therapy in Endometriosis via openalex
- Uterine adenomyosis in persistence of dysmenorrhea after surgical excision of pelvic endometriosis and colorectal resection. via openalex
- Uterine adenomyosis in the infertility clinic via openalex
- W3183294355 via openalex
- W3210570897 via openalex
- W4200596131 via openalex
- W4211103501 via openalex
- W4213245349 via openalex
- W4255815262 via openalex
- W4317390883 via openalex
- W4318173907 via openalex
- W4366990263 via openalex
- W4388500912 via openalex
- W4392906041 via openalex
- W4394733854 via openalex
- W4396625402 via openalex
- W4399823419 via openalex
- W4401956466 via openalex
- W4402485095 via openalex
- W4402517540 via openalex
- W4407694047 via openalex
- W6605217402 via openalex
- W6697565686 via openalex
- W6703470536 via openalex
- W6805294970 via openalex
- W6851773518 via openalex
- W6862957409 via openalex
- W6869492600 via openalex
- W1949741502 via openalex
- W1980292582 via openalex
- W1980422861 via openalex
- W2015019618 via openalex
- W2017057381 via openalex
- W2030284622 via openalex
- W2072724311 via openalex
- W2073300038 via openalex
- W2090152451 via openalex
- W2093135399 via openalex
- W2093227175 via openalex
- W2105101447 via openalex
- W2106684817 via openalex
- W2114428497 via openalex
- W2152508754 via openalex
- W2162646944 via openalex
- W2614566443 via openalex
- W2811372969 via openalex
- W2921747719 via openalex
- W2980789836 via openalex
- W3046196569 via openalex
- W3086825014 via openalex
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-20T00:31:22.508620+00:00
License: CC0
· commercial use OK